These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27536672)

  • 1. Management of Membranous Nephropathy in Asia.
    Xu J; Hu X; Xie J; Chen N
    Kidney Dis (Basel); 2015 Sep; 1(2):119-25. PubMed ID: 27536672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Membranous Nephropathy in Western Countries.
    Alfaadhel T; Cattran D
    Kidney Dis (Basel); 2015 Sep; 1(2):126-37. PubMed ID: 27536673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China.
    Wu L; Lai J; Ling Y; Weng Y; Zhou S; Wu S; Jiang S; Ding X; Jin X; Yu K; Chen Y
    Med Sci Monit; 2021 Feb; 27():e930097. PubMed ID: 33550324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
    Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
    Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of current and alternative therapies for idiopathic membranous nephropathy.
    Tran TH; J Hughes G; Greenfeld C; Pham JT
    Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus Nephritis in Asia: Clinical Features and Management.
    Yap DY; Chan TM
    Kidney Dis (Basel); 2015 Sep; 1(2):100-9. PubMed ID: 27536670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern view on treatment of membranous nephropathy].
    Bobkova IN; Kamyshova ES
    Ter Arkh; 2020 Jul; 92(6):99-104. PubMed ID: 33346502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis.
    Shan W; Guan H; Gu H; Wang R; Huang X; Li P; Xie Y; Bao K; Qin X
    Heliyon; 2024 Apr; 10(7):e28836. PubMed ID: 38596093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
    Cattran DC
    Semin Nephrol; 2003 May; 23(3):272-7. PubMed ID: 12838495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.
    Xue C; Zhou CC; Wu M; Mei CL
    Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China.
    Pan Y; Chen WD; Liu L; Yang H; Chang B; Cui C
    Immunotargets Ther; 2024; 13():385-398. PubMed ID: 39081263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y
    Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K
    Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.